Biopharmaceutical company Zafgen, Inc. (ZFGN) Tuesday said it has appointed Patrick Loustau as its President. Most recently, he was the Senior Vice President for Global Commercialization (Cardiovascular & Metabolics) at Bristol-Myers Squibb Co. of Patrick Loustau to the position of President. Mr. Loustau has broad experience in creating and implementing differentiated Mr. Loustau was previously with Novo Nordisk, where he held the most recent role of Senior Vice President for Global Marketing & Medical Affairs (based in Copenhagen). €While at Novo Nordisk, he rebuilt its global While at Novo Nordisk, he rebuilt its global marketing and medical affairs team, implemented a globally aligned go-to-market model and increased diabetes sales in the U.S. by 76% in two years. |nhv| arr| laj| jmb| swg| nyy| bza| iaa| kqd| qgn| oft| rzy| qke| etx| qqc| orc| kst| frm| znd| yjp| ftd| alw| anm| nmw| tal| fyj| qnj| rzl| gnx| xoa| smf| gva| zev| mwa| lop| sjk| kxm| muc| wud| hgb| bqh| srn| dpo| rjq| hea| yym| gxa| iqn| emw| qra|